PSYENCE BIOMEDICAL LTD (PBM)

CA74449F1009 - Common Stock

0.6  +0 (+0.33%)

After market: 0.55 -0.05 (-8.33%)

News Image
2 hours ago - Chartmill

Stay updated with the stocks that are on the move in today's after-hours session.

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

News Image
a month ago - Psyence Biomedical Ltd.

Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will...

News Image
2 months ago - Psyence Biomedical Ltd.

Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that its Australian...

News Image
3 months ago - Psyence Group Inc.

Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Further to the announcement by Psyence Group Inc (

News Image
3 months ago - Psyence Biomedical Ltd.

Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin

 The study, published in the journal Molecular Psychiatry, suggests that nature-derived psilocybin may be demonstrably more therapeutic than its synthetic...

News Image
3 months ago - Psyence Biomedical Ltd.

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on March 11, 2024, it received two...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning!

News Image
3 months ago - Psyence Group Inc.

Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (

News Image
3 months ago - Psyence Biomedical Ltd.

Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones

TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM), a clinical-stage life science biotechnology company pioneering the use...

News Image
3 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Pre-market stock movers are a great way to start the week as we check out all of the biggest trades happening on Monday morning!

News Image
3 months ago - Psyence Group Inc.

Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division

TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- Further to the announcement by Psyence Group Inc (

News Image
3 months ago - InvestorPlace

Why Is Psyence Biomedical (PBM) Stock Up 90% Today?

With Psyence Biomedical moving into a Phase 2B trial, the credibility boost for its psychedelics-based drug lifted PBM stock.

News Image
4 months ago - Psyence Biomedical Ltd.

Psyence Biomedical’s Subsidiary, Psyence Australia, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (NASDAQ:PBM) (

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

We're starting Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!